SEARCH

SEARCH BY CITATION

References

  • Beal M. F. (2002) Coenzyme Q10 as a possible treatment for neurodegenerative diseases. Free Radic. Biol. Med. 32, 797803.
  • Bindokas V. P., Jordâan J., Lee C. C. and Miller R. J. (1996) Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 16, 13241336.
  • Biswas S. C., Ryu E., Park C., Malagelada C. and Greene L. A. (2005) Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease. Neurochem. Res. 30, 839845.
  • Blum D., Torch S., Lambeng N., Nissou M., Benabid A. L., Sadoul R. and Verna J. M. (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65, 135172.
  • Boehning D., Patterson R. L., Sedaghat L., Glebova N. O., Kurosaki T. and Snyder S. H. (2003) Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat. Cell Biol. 5, 10511061.
  • Breckenridge D. G., Germain M., Mathai J. P., Nguyen M. and Shore G. C. (2003) Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22, 86088618.
  • Chandra D., Choy G., Daniel P. T. and Tang D. G. (2005) Bax-dependent regulation of Bak by voltage-dependent anion channel 2. J. Biol. Chem. 280, 19 05119 061.
  • Cheng E. H., Sheiko T. V., Fisher J. K., Craigen W. J. and Korsmeyer S. J. (2003) VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301, 513517.
  • Choi J., Conrad C. C., Dai R., Malakowsky C. A., Talent J. M., Carroll C. A., Weintraub S. T. and Gracy R. W. (2003) Vitamin E prevents oxidation of antiapoptotic proteins in neuronal cells. Proteomics 3, 7377.
  • Choi W.-S., Yoon S.-Y., Oh T. H., Choi E.-J., O'Malley K. L. and Oh Y. J. (1999) Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J. Neurosci. Res. 57, 8694.
  • Choi W.-S., Eom D. S., Han B. S., Kim W. K., Han B. H., Choi E. J., Oh T. H., Markelonis G. J., Cho J. W. and Oh Y. J. (2004) Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J. Biol. Chem. 279, 20 45120 460.
  • Von Coelln R., Kugler S., Bahr M., Weller M., Dichgans J. and Schulz J. B. (2001) Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J. Neurochem. 77, 263273.
  • Cohen G. and Heikkila R. E. (1974) The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249, 24472452.
  • Curtius H. C., Wolfensberger M., Steinmann B., Redweik U. and Siegfried J. (1974) Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J. Chromatogr. 99, 529540.
  • Dalle-Donne I., Giustarini D., Colombo R., Rossi R. and Milzani A. (2003) Protein carbonylation in human diseases. Trends Mol. Med. 9, 169176.
  • Danial N. N. and Korsmeyer S. J. (2004) Cell death: critical control points. Cell 116, 205219.
  • Darios F., Lambeng N., Troadec J. D., Michel P. P. and Ruberg M. (2003) Ceramide increases mitochondrial free calcium levels via caspase 8 and Bid: role in initiation of cell death. J. Neurochem. 84, 643654.
  • Elkon H., Melamed E. and Offen D. (2004) Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J. Mol. Neurosci. 24, 387400.
  • Eriksen J. L., Wszolek Z. and Petrucelli L. (2005) Molecular pathogenesis of Parkinson disease. Arch. Neurol. 62, 353357.
  • Fornstedt B., Rosengren E. and Carlsson A. (1986) Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology 25, 451454.
  • Gao S., Fu W., Durrenberger M., De Geyter C. and Zhang H. (2005) Membrane translocation and oligomerization of hBok are triggered in response to apoptotic stimuli and Bnip3. Cell. Mol. Life Sci. 62, 10151024.
  • Graham D. G., Tiffany S. M., Bell W. R. Jr and Gutknecht W. F. (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14, 644653.
  • Gutteridge J. M. and Halliwell B. (2000) Free radicals and antioxidants in the year 2000. A historical look to the future. Ann. N. Y. Acad. Sci. 899, 136147.
  • Harding H. P., Zhang Y., Zeng H. et al. (2003) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11, 619633.
  • Hastings T. G., Lewis D. A. and Zigmond M. J. (1996) Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv. Exp. Med. Biol. 387, 97106.
  • Haynes C. M., Titus E. A. and Cooper A. A. (2004) Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol. Cell 15, 767776.
  • Heikkila R. and Cohen G. (1972) Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine. Potentiation by ascorbic acid. Mol. Pharmacol. 8, 241248.
  • Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L. and Korsmeyer S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241251.
  • Hofer A. and Gasser T. (2004) New aspects of genetic contributions to Parkinson's disease. J. Mol. Neurosci. 24, 417424.
  • Holtz W. A. and O'Malley K. L. (2003) Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J. Biol. Chem. 278, 19 36719 377.
  • Holtz W. A., Turetzky J. M. and O'Malley K. L. (2005) Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death. Antioxid. Redox Signal. 7, 639648.
  • Izumi Y., Sawada H., Sakka N., Yamamoto N., Kume T., Katsuki H., Shimohama S. and Akaike A. (2005) p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J. Neurosci. Res. 79, 849860.
  • Jenner P. (2003) Oxidative stress in Parkinson's disease. Ann. Neurol. 53, S26S38.
  • Jensen P. J., Alter B. J. and O'Malley K. L. (2003) Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. J. Neurochem. 86, 196209.
  • Keller J. N., Huang F. F., Dimayuga E. R. and Maragos W. F. (2000) Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radic. Biol. Med. 29, 10371042.
  • Kowaltowski A. J., Castilho R. F. and Vercesi A. E. (2001) Mitochondrial permeability transition and oxidative stress. FEBS Lett. 495, 1215.
  • Le Bras M., Clement M. V., Pervaiz S. and Brenner C. (2005) Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol. Histopathol. 20, 205219.
  • Lotharius J., Dugan L. L. and O'Malley K. L. (1999) Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 19, 12841293.
  • Matsuzawa A. and Ichijo H. (2005) Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid. Redox Signal. 7, 472481.
  • McNaught K. S., Bjèorklund L. M., Belizaire R., Isacson O., Jenner P. and Olanow C. W. (2002a) Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport 13, 14371441.
  • McNaught K. S., Mytilineou C., Jnobaptiste R., Yabut J., Shashidharan P., Jenner P. and Olanow C. W. (2002b) Impairment of the ubiquitin–proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J. Neurochem. 81, 301306.
  • Momoi T. (2004) Caspases involved in ER stress-mediated cell death. J. Chem. Neuroanat. 28, 101105.
  • Nair V. D. (2006) Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease. Apoptosis 11, 955966.
  • Nakagawa T. and Yuan J. (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell. Biol. 150, 887894.
  • Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B. A. and Yuan J. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403, 98103.
  • Nutt L. K., Pataer A., Pahler J., Fang B., Roth J., McConkey D. J. and Swisher S. G. (2002) Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca2+ stores. J. Biol. Chem. 277, 92199225.
  • Nystrom T. (2005) Role of oxidative carbonylation in protein quality control and senescence. EMBO J. 24, 13111317.
  • O'Malley K. L., Liu J., Lotharius J. and Holtz W. (2003) Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons. Neurobiol. Dis. 14, 4351.
  • Oakes S. A., Scorrano L., Opferman J. T., Bassik M. C., Nishino M., Pozzan T. and Korsmeyer S. J. (2005) Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc. Natl Acad. Sci. USA 102, 105110.
  • Oh J. H., Choi W. S., Kim J. E., Seo J. W., O'Malley K. L. and Oh Y. J. (1998) Overexpression of HA-Bax but not Bcl-2 or Bcl-XL attenuates 6-hydroxydopamine-induced neuronal apoptosis. Exp. Neurol. 154, 193198.
  • Oh Y., Wong S., Moffat M. and O'Malley K. L. (1995) Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line. Neurobiol. Dis. 2, 157167.
  • Rao R. V., Castro-Obregon S., Frankowski H., Schuler M., Stoka V., Del Rio G., Bredesen D. E. and Ellerby H. M. (2002) Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J. Biol. Chem. 277, 21 83621 842.
  • Reimertz C., Kèogel D., Rami A., Chittenden T. and Prehn J. H. (2003) Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. J. Cell Biol. 162, 587597.
  • Reverter-Branchat G., Cabiscol E., Tamarit J. and Ros J. (2004) Oxidative damage to specific proteins in replicative and chronological-aged Saccharomyces cerevisiae: common targets and prevention by calorie restriction. J. Biol. Chem. 279, 31 98331 989.
  • Rutkowski D. T. and Kaufman R. J. (2004) A trip to the ER: coping with stress. Trends Cell Biol. 14, 2028.
  • Ryu E. J., Harding H. P., Angelastro J. M., Vitolo O. V., Ron D. and Greene L. A. (2002) Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 22, 10 69010 698.
  • Ryu E. J., Angelastro J. M. and Greene L. A. (2005) Analysis of gene expression changes in a cellular model of Parkinson disease. Neurobiol. Dis. 18, 5474.
  • Saner A. and Thoenen H. (1971) Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Mol. Pharmacol. 7, 147154.
  • Schroder M. and Kaufman R. J. (2005) The mammalian unfolded protein response. Annu. Rev. Biochem. 74, 739789.
  • Scorrano L., Oakes S. A., Opferman J. T., Cheng E. H., Sorcinelli M. D., Possan T. and Korsmeyer S. L. (2003) BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300, 135139.
  • Shringarpure R., Grune T., Mehlhase J. and Davies K. J. (2003) Ubiquitin conjugation is not required for the degradation of oxidised proteins by proteasome. J. Biol. Chem 278, 311318.
  • Silva R. M., Ries V., Oo T. F. et al. (2005) CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J. Neurochem. 95, 974986.
  • Sitia R. and Molteni S. N. (2004) Stress, protein (mis) folding, and signaling: the redox connection. Sci. STKE 2004, pe27.
  • Snider B. J., Tee L. Y., Canzoniero L. M., Babcock D. J. and Choi D. W. (2002) NMDA antagonists exacerbate neuronal death caused by proteasome inhibition in cultured cortical and striatal neurons. Eur. J. Neurosci. 15, 419428.
  • Snyder H. and Wolozin B. (2004) Pathological proteins in Parkinson's disease: focus on the proteasome. J. Mol. Neurosci. 24, 425442.
  • Spencer J. P., Jenner P., Daniel S. E., Lees A. J., Marsden D. C. and Halliwell B. (1998) Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J. Neurochem. 71, 21122122.
  • Stokes A. H., Hastings T. G. and Vrana K. E. (1999) Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55, 659665.
  • Sun X. M., Butterworth M., MacFarlane M., Dubiel W., Ciechanover A. and Cohen G. M. (2004) Caspase activation inhibits proteasome function during apoptosis. Mol. Cell 14, 8193.
  • Takahashi R. and Imai Y. (2003) Pael receptor, endoplasmic reticulum stress, and Parkinson's disease. J. Neurol. 250: III25III29.
  • Tu B. P. and Weissman J. S. (2004) Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell Biol. 164, 341346.
  • Yakovlev A. G., Di Giovanni S., Wang G., Liu W., Stoica B. and Faden A. I. (2004) BOK and NOXA are essential mediators of p53-dependent apoptosis. J. Biol. Chem. 279, 28 36728 374.
  • Zafarullah M., Li W. Q., Sylvester J. and Ahmad M. (2003) Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci. 60, 620.